The return of thalidomide: new uses and renewed concerns--reply.
Leiden University Medical Centre, The Netherlands.
Ben
B
Naafs
D014943:Global Health; D006291:Health Policy; D006801:Humans; D007917:Leprostatic Agents / Q000009:adverse effects*; D007918:Leprosy / Q000188:drug therapy*; D013792:Thalidomide / Q000009:adverse effects*; D014944:World Health Organization
D007917:Leprostatic Agents; D013792:Thalidomide